SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, today announced the successful ...

SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients transitioning from hospital to ...

The US Food and Drug Administration (FDA) has approved Element Science’s premarket approval application for its Jewel Patch Wearable Cardioverter Defibrillator (Patch-WCD) intended for cardiac care.

Element Science plans to use the funds to complete clinical studies and launch its product, a wearable defibrillator designed to detect and treat arrhythmias in patients with an elevated risk of ...